这下55的目标价都显得保守了查看全文
美股医药Z博士2018-02-27 09:28
$Aimmune Therapeutics, Inc.(AIMT)$ 公司在上周刚刚公布了花生过敏药物的III期临床数据,数据非常优秀。但因去年10月份竞争对手DBVT的试验失败,公司的股价被一路追捧,导致上周数据公布后SELL ON NEWS。加上公司立刻推出的增发,增发价32,致使股价一路走跌。周一股票增发正式结束,多名公司的管...查看全文
张小丰2018-02-20 22:01
$Aimmune Therapeutics, Inc.(AIMT)$ 很亮Aimmune Therapeutics’ Pivotal Phase 3 PALISADE Trial of AR101 Meets Primary Endpoint in Patients With Peanut Allergy
Landmark 554-patient Phase 3 study met the primary efficacy endpoint, as 67.2% of AR101 patients ages 4–17 tolerat...查看全文
琳子的日复一日2018-02-20 21:10
$Aimmune Therapeutics, Inc.(AIMT)$
花生过敏症三期结果公布,盘前大涨!Aimmune Therapeutics Inc (NASDAQ:AIMT)获得加拿大皇家银行“优于大盘”评级,目标价55美元。查看全文
资本主义拉美行不通2018-02-13 23:04
$Aimmune Therapeutics, Inc.(AIMT)$ 欧美国家预计有3000万人对某一种食物过敏,其中花生过敏是最常见的过敏类型。Aimmune的候选药物AR10能够让花生过敏患者正常食用花生。查看全文
淘沙见金2017-10-21 08:35
贝壳兄弟这次又猜错了,这把赔的可够多啊,账面上至少少了130多个million
。相反,$Aimmune Therapeutics, Inc.(AIMT)$ 背后的股东要笑了,包括AISLING CAPITAL和POINT72 ASSET MANAGEMENT等。这场景是多么的似曾相似啊
查看全文
$Aimmune治疗(AIMT)$ 8-K Current report, items 1.02, 2.01, 2.04, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-20-272122 Act: 34 Size: 258 KB 网页链接
$Aimmune治疗(AIMT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-028359 Size: 9 KB 网页链接
$Aimmune治疗(AIMT)$ 内部交易: 2020-10-13,10% Owner,Societe des Produits Nestle S. ,买入,54117287普通股, $34.50
$Aimmune治疗(AIMT)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-20-268644 Act: 33 Size: 20 KB 网页链接
$Aimmune治疗(AIMT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-268646 Act: 33 Size: 25 KB 网页链接
$Aimmune治疗(AIMT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-268648 Act: 33 Size: 25 KB 网页链接
$Aimmune治疗(AIMT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-268649 Act: 33 Size: 25 KB 网页链接
$Aimmune治疗(AIMT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-268654 Act: 33 Size: 25 KB 网页链接
$Aimmune治疗(AIMT)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-20-268640 Act: 33 Size: 20 KB 网页链接
$Aimmune治疗(AIMT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-268641 Act: 33 Size: 25 KB 网页链接